Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vessela Kristensen

Showing results (41-50 of 97) with videos related to

Pageof 10
Sort By:
Clinical Epigenetics|June 12, 2023
Buffy coat signatures of breast cancer risk in a prospective cohort studyFelicia Fei-Lei Chung, Sandra González Maldonado, Amelie Nemc, et al.
Genome Medicine|December 1, 2018
Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrationsElen Kristine Höglander, Silje Nord, David C Wedge, et al.
Human Mutation|June 21, 2006
A quality assessment survey of SNP genotyping laboratoriesPäivi Lahermo, Ulrika Liljedahl, Grethe Alnaes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 11, 2017
The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast CancerLaxmi Silwal-Pandit, Silje Nord, Hedda von der Lippe Gythfeldt, et al.
Nature Communications|April 17, 2019
Partially methylated domains are hypervariable in breast cancer and fuel widespread CpG island hypermethylationArie B Brinkman, Serena Nik-Zainal, Femke Simmer, et al.
BMC Cancer|December 18, 2015
A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patientsPetra Seibold, Peter Schmezer, Sabine Behrens, et al.
Human Molecular Genetics|January 8, 2009
Association of ESR1 gene tagging SNPs with breast cancer riskAlison M Dunning, Catherine S Healey, Caroline Baynes, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 7, 2016
Genetic modifiers of CHEK2*1100delC-associated breast cancer riskTaru A Muranen, Dario Greco, Carl Blomqvist, et al.
Human Genetics|December 2, 2015
Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association ConsortiumJieping Lei, Anja Rudolph, Kirsten B Moysich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 9, 2016
Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC CarriersMarjanka K Schmidt, Frans Hogervorst, Richard van Hien, et al.
Pageof 10

Showing results (41-50 of 97) with videos related to

Sort By:
Pageof 10
Clinical Epigenetics|June 12, 2023
Buffy coat signatures of breast cancer risk in a prospective cohort studyFelicia Fei-Lei Chung, Sandra González Maldonado, Amelie Nemc, et al.
Genome Medicine|December 1, 2018
Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrationsElen Kristine Höglander, Silje Nord, David C Wedge, et al.
Human Mutation|June 21, 2006
A quality assessment survey of SNP genotyping laboratoriesPäivi Lahermo, Ulrika Liljedahl, Grethe Alnaes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 11, 2017
The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast CancerLaxmi Silwal-Pandit, Silje Nord, Hedda von der Lippe Gythfeldt, et al.
Nature Communications|April 17, 2019
Partially methylated domains are hypervariable in breast cancer and fuel widespread CpG island hypermethylationArie B Brinkman, Serena Nik-Zainal, Femke Simmer, et al.
BMC Cancer|December 18, 2015
A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patientsPetra Seibold, Peter Schmezer, Sabine Behrens, et al.
Human Molecular Genetics|January 8, 2009
Association of ESR1 gene tagging SNPs with breast cancer riskAlison M Dunning, Catherine S Healey, Caroline Baynes, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 7, 2016
Genetic modifiers of CHEK2*1100delC-associated breast cancer riskTaru A Muranen, Dario Greco, Carl Blomqvist, et al.
Human Genetics|December 2, 2015
Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association ConsortiumJieping Lei, Anja Rudolph, Kirsten B Moysich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 9, 2016
Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC CarriersMarjanka K Schmidt, Frans Hogervorst, Richard van Hien, et al.
Pageof 10